Tomiyasu Murata

Nagoya, 4688503, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Extracellular regucalcin blocks the proliferation and metastatic activity of SK-N-SH human neuroblastoma cells by targeting diverse signaling pathways: Involvement in the cancer cell microenvironment.

Extracellular regucalcin blocks the proliferation and metastatic activity of SK-N-SH human neuroblastoma cells by targeting diverse signaling pathways: Involvement in the cancer cell microenvironment.

Journal: Cellular signalling

Published: May 04, 2026

Extracellular regucalcin reveals anti-cancer activity by suppressing cell growth and metastatic activity by blocking EGF signaling pathway in human glioblastoma cells in vitro.

Extracellular regucalcin reveals anti-cancer activity by suppressing cell growth and metastatic activity by blocking EGF signaling pathway in human glioblastoma cells in vitro.

Journal: Cellular signalling

Published: February 14, 2025

Involvement of glucagon-like peptide-1 receptor in fisetin tetramethyl ether-enhanced insulin secretion in MIN6 cells.

Involvement of glucagon-like peptide-1 receptor in fisetin tetramethyl ether-enhanced insulin secretion in MIN6 cells.

Journal: European journal of pharmacology

Published: January 31, 2025

Overexpression of RGPR-p117 reveals anticancer effects by regulating multiple signaling pathways in bone metastatic human breast cancer MDA-MB-231 cells.

Overexpression of RGPR-p117 reveals anticancer effects by regulating multiple signaling pathways in bone metastatic human breast cancer MDA-MB-231 cells.

Journal: IUBMB life

Published: September 18, 2024

The inflammatory macrophages repress the growth of bone metastatic human prostate cancer cells via TNF-α and IL-6 signaling: Involvement of cell signaling regulator regucalcin.

The inflammatory macrophages repress the growth of bone metastatic human prostate cancer cells via TNF-α and IL-6 signaling: Involvement of cell signaling regulator regucalcin.

Journal: Cellular signalling

Published: February 21, 2023

The overexpressed regucalcin represses the growth via regulating diverse pathways linked to EGF signaling in human ovarian cancer SK-OV-3 cells: Involvement of extracellular regucalcin.

The overexpressed regucalcin represses the growth via regulating diverse pathways linked to EGF signaling in human ovarian cancer SK-OV-3 cells: Involvement of extracellular regucalcin.

Journal: Life sciences

Published: October 18, 2022

The overexpressed transcription factor RGPR-p117 suppresses the proliferation of normal rat kidney proximal tubular epithelial NRK-52E cells: Involvement of diverse signaling pathways.

The overexpressed transcription factor RGPR-p117 suppresses the proliferation of normal rat kidney proximal tubular epithelial NRK-52E cells: Involvement of diverse signaling pathways.

Journal: Life sciences

Published: May 02, 2022

Extracellular Regucalcin Suppresses the Growth, Migration, Invasion, and Adhesion of Metastatic Human Prostate Cancer Cells.

Extracellular Regucalcin Suppresses the Growth, Migration, Invasion, and Adhesion of Metastatic Human Prostate Cancer Cells.

Journal: Oncology

Published: February 18, 2022

Overexpression of regucalcin blocks the migration, invasion, and bone metastatic activity of human prostate cancer cells: Crosstalk between cancer cells and bone cells.

Overexpression of regucalcin blocks the migration, invasion, and bone metastatic activity of human prostate cancer cells: Crosstalk between cancer cells and bone cells.

Journal: The Prostate

Published: November 10, 2021

The phytochemical p-hydroxycinnamic acid suppresses the growth and stimulates the death in human liver cancer HepG2 cells.

The phytochemical p-hydroxycinnamic acid suppresses the growth and stimulates the death in human liver cancer HepG2 cells.

Journal: Anti-cancer drugs

Published: February 17, 2021

(S)-Erypoegin K, an isoflavone isolated from Erythrina poeppigiana, is a novel inhibitor of topoisomerase IIα: Induction of G2 phase arrest in human gastric cancer cells.

(S)-Erypoegin K, an isoflavone isolated from Erythrina poeppigiana, is a novel inhibitor of topoisomerase IIα: Induction of G2 phase arrest in human gastric cancer cells.

Journal: Bioorganic & medicinal chemistry

Published: October 31, 2020

Progression-free survival of prostate cancer patients is prolonged with a higher regucalcin expression in the tumor tissues: Overexpressed regucalcin suppresses the growth and bone activity in human prostate cancer cells.

Progression-free survival of prostate cancer patients is prolonged with a higher regucalcin expression in the tumor tissues: Overexpressed regucalcin suppresses the growth and bone activity in human prostate cancer cells.

Journal: Translational oncology

Published: August 20, 2020

Showing 1-12 of 44

Last Updated: 09/26/2026